Ensysce Biosciences, Inc.
ENSCNASDAQHealthcareBiotechnology
As of Oct 15, 2026 close
- Market cap
- $7.79M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.23$2.75
- Volume (live)
- -
- Avg. volume (3M)
- 592.51K
Ensysce Biosciences (ENSC) Stock Price & Financial Analysis
Ensysce Biosciences Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.55 - $0.60 |
|---|---|
| 52-Week High | $2.75 |
| 52-Week Low | $0.23 |
| Open | $0.56 |
| Volume (last close) | 331.72K |
| Average Volume (3M) | 592.51K |
| Revenue (TTM) | 1.16M |
|---|---|
| Net Income (TTM) | -12.62M |
| Free Cash Flow (TTM) | -8.98M |
| EPS (TTM) | −$1.91 |
| Profit Margin | -1084.23% |
| Operating Margin | -1087.47% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 7.79M |
|---|---|
| Shares Outstanding | 13.04M |
| Price to Sales (P/S) | 6.69 |
| Price to Book (P/B) | -9.97 |
| EV/EBITDA | -0.58 |
| 50-Day MA | $0.43 |
|---|---|
| 200-Day MA | $0.46 |
| 1-Year Change | −76.74% |
Source: Market prices and company fundamentals. Data as of Oct 15, 2026. Data sources and methodology
Ensysce Biosciences at a Glance
As of the Oct 15, 2026 close, Ensysce Biosciences (ENSC) has a market capitalization of $7.79M. The stock trades at 6.7× sales. Over the trailing twelve months it lost $12.62M on revenue of $1.16M and burned $8.98M of free cash flow. Revenue fell 44.5% year over year.
As of its latest reported balance sheet, it holds $676.70K in cash and securities against $196.84K of debt, a net cash position of $479.86K.
Ensysce Biosciences does not currently pay a dividend.
The share price is down 76.7% over the past year. At $0.60 (the Oct 15, 2026 close) it sits near the bottom of its 52-week range of $0.23 to $2.75, above its 200-day moving average of $0.46.
Frequently Asked Questions About Ensysce Biosciences
What is the current stock price for ENSC?
As of the Oct 15, 2026 close, ENSC stock trades at $0.60. The 52-week range is $0.23–$2.75, with a day range of $0.55–$0.60.
What is the P/E ratio for ENSC?
The P/E ratio (Price-to-Earnings) for ENSC is shown in the Key Statistics section. This valuation metric helps compare Ensysce Biosciences, Inc. to industry peers.
Does ENSC pay dividends?
Ensysce Biosciences does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for ENSC?
Analyst ratings and recommendations for ENSC are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of ENSC?
As of the Oct 15, 2026 close, Ensysce Biosciences's market capitalization is $7.8M, classifying it as a micro-cap company. Ensysce Biosciences operates in the Healthcare sector within the Biotechnology industry.